Figure S1 from Combination of the Circulating Tumor Cell Enumeration and the Fecal Immunochemical Test for Colorectal Neoplasia Prediction and Risk Evaluation of Colorectal Cancer

Comparative performance of FIT and combined models. Comparison of performance of using FIT results only and combination of triple-marker models (FIT results + CD45neg EpCAMpos CTCs + CD45neg EpCAMneg cells) for differentiating the individuals with colorectal neoplasia from the normal subjects (76 individuals with colorectal neoplasia vs. 37 normal subjects) (*: statistical difference p < 0.05). Cut-off values for FIT results, CD45neg EpCAMpos CTCs, and CD45neg EpCAMneg cells were 100 ng/mL, 6 cells/7mL blood, and 300 cells/7mL blood, respectively.